Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · Real-Time Price · USD
0.125
-0.007 (-5.59%)
At close: Feb 21, 2025, 4:00 PM
0.127
+0.002 (1.60%)
After-hours: Feb 21, 2025, 7:59 PM EST
Petros Pharmaceuticals Employees
Petros Pharmaceuticals had 21 employees as of December 31, 2023. The number of employees decreased by 3 or -12.50% compared to the previous year.
Employees
21
Change (1Y)
-3
Growth (1Y)
-12.50%
Revenue / Employee
$191,542
Profits / Employee
-$945,170
Market Cap
1.25M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 21 | -3 | -12.50% |
| Dec 31, 2022 | 24 | 0 | - |
| Dec 31, 2021 | 24 | -3 | -11.11% |
| Dec 31, 2020 | 27 | -18 | -40.00% |
| Dec 31, 2019 | 45 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
PTPI News
- 4 days ago - Petros Pharmaceuticals Announces Pricing of $9.6 Million Public Offering of Common Stock and Warrants - Accesswire
- 11 days ago - NextTrip Closes on 49% Stake in Five Star Alliance - Accesswire
- 16 days ago - NextTrip Invests in Luxury Travel Brand Five Star Alliance to secure 49% Stake with an Option to Purchase a Controlling Interest - Accesswire
- 6 weeks ago - Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules - Accesswire
- 2 months ago - Petros Pharmaceuticals Featured in “New Era of Healthcare, AI, Data and Consumer Empowerment” - Accesswire
- 2 months ago - Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annually - Accesswire
- 2 months ago - NextTrip Launches Advertising on Compass.tv in Collaboration with Leap Media Group - Accesswire
- 3 months ago - NextTrip Plans to Acquire Luxury Travel Company Five Star Alliance - Accesswire